PBDA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Protalix Biotherapeutics Inc

Watchlist Manager

Watchlist

Price: 2.255 EUR

Market Cap: €165.3m

	Protalix Biotherapeutics Inc F:PBDA	US
	TELUS International (CDA) Inc TSX:TIXT	CA
S	Sonic Interfreight PCL SET:SONIC	TH
	Lifenet Insurance Co F:7XJ	JP
A	Alpha Divisions PCL SET:ALPHAX	TH
E	Everpure Inc F:6PU	US
C	ConocoPhillips BMV:COP	US
E	Edel SE & Co KgaA XMUN:EDL	DE
U	United Rentals Inc XMUN:UR3	US
S	Southern Co XMUN:SOT	US
P	PICC Property and Casualty Co Ltd OTC:PPCCY	CN
	F5 Inc BMV:FFIV	US
P	PostNL NV DUS:TNTC	NL
	Straits Trading Company Ltd F:W2F	SG
M	Meritage Homes Corp F:MEY	US

Profitability Summary

Protalix Biotherapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

69%

Strong 3Y Average Gross Margin

55%

Declining Gross Margin

74% > 69%

Healthy Operating Margin

29%

Low 3Y Average Operating Margin

Operating Margin is Increasing

21% > 29%

Healthy Net Margin

23%

Low 3Y Average Net Margin

Net Margin is Increasing

17% > 23%

Healthy Free Cash Flow Margin

10%

Negative 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-14% > 10%

Exceptional ROE

31%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.